results

EmPRO Reports Another Year of Strong Financial Results with Significant Growth in Net Income and Surplus During 2025

ROSLYN, N.Y., April 13, 2026 (GLOBE NEWSWIRE) -- EmPRO Insurance Company (EmPRO), a licensed medical professional liability insurance carrier serving…

1 day ago

Magnite to Announce First Quarter 2026 Financial Results on May 6, 2026

April 06, 2026 08:00 ET  | Source: Magnite, Inc. NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- Magnite (Nasdaq: MGNI),…

1 week ago

Wix Announces Final Results of Modified Dutch Auction Tender Offer

NEW YORK—Wix.com Ltd. (Nasdaq: WIX) (“Wix” or the “Company”) today announced the final results of its “modified Dutch Auction” tender…

2 weeks ago

Zoomlion Reports 2025 Results With International Revenue Approaching 60% of Total

Global reach and diversified businesses continue to support growthCHANGSHA, China, April 2, 2026 /PRNewswire/ -- Zoomlion Heavy Industry Science &…

2 weeks ago

Wix Announces Preliminary Results of Modified Dutch Auction Tender Offer

NEW YORK, April 2, 2026—Wix.com Ltd. (Nasdaq: WIX) (“Wix” or the “Company”) today announced the preliminary results of its “modified…

2 weeks ago

Bybit Extends Tomorrowland Brasil Partnership Into 2027 Following Strong 2025 Results

DUBAI, UAE, March 31, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has announced the continuation…

2 weeks ago

SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD

TAMPA, Fla., March 31, 2026 /PRNewswire/ -- Concept Medical Inc. (CMI), a global leader in innovative drug-delivery technology across vascular…

2 weeks ago

Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update

– Released positive topline data from Phase 1 study of IV rademikibart in patients with asthma or COPD – –…

2 weeks ago

Jiayin Group Inc. Reports Fourth Quarter and Fiscal Year 2025Unaudited Financial Results

SHANGHAI, March 31, 2026 (GLOBE NEWSWIRE) -- Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform…

2 weeks ago

MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting

Results from the Phase 3 VELA clinical trials in adults with moderate-to-severe hidradenitis suppurativa (HS) show that clinical responses continue…

2 weeks ago